Medical Science Liaison Society Again Selects Boston for 2015 Conference

HIGHLAND CITY, Fla. - May 27, 2015 - PRLog -- The Medical Science Liaison Society (MSL Society) — the world’s first and only non-profit organization dedicated to the advancement of the medical science liaison (MSL) role in the pharmaceutical and other healthcare industries — has announced its 2015 North American conference will be held in Boston, MA for the second consecutive year, and will be hosted by Genzyme. Slated for September 29 to October 1, 2015, the event is open to anyone within the global MSL community including members, non-members, and students.

Building on the momentum established during its previous U.S., European, and Asia-Pac meetings, the society’s 3rd annual North American conference will give attendees the opportunity to learn and share the latest best practices, hear innovative strategies for improving MSL performance, network with colleagues, and meet new peers while discussing relevant topics and recent news.

The conference will feature esteemed speakers from around the world discussing topics such as:

•     "Leveraging MSL Insights from the Field to Advance Medicine”by Avery Ince, Global VP of Johnson & Johnson (China).

•     “The Pathway to Professional Certification in Medical Affairs: A Journey to Professional Excellence” by J. Hudson Garrett Jr., Vice President of Clinical Affairs at PDI Inc. (USA).

•     “Challenges Faced by the MSL Function” by Kumaran Krishnan, European Medical Affairs Centre of Excellence at Sanofi (UK).

•     “Empowerment, Transformational Leadership, and Intention to Quit in a Medical Science Liaison Team” by Dr. Jerome Meyer, Regional MSL Director at Genzyme Pharmaceuticals (USA).

•     “A New SAE: Skills, Attributes and Effectiveness for MSL’s Working with Rare Diseases” by James D. Czajkowski, President of Phase Medical LLC (USA).

Presentations will also be given by other global medical affairs leaders including Alexander Tolmachev of Takeda (Russia), Michael Milane of DUSA Pharmaceuticals (USA), and Jennifer Williams of Bard Medical (USA).

On the conference’s roster of speakers, five are members of the recently launched MSL Society Global Advisory Committee: Krishnan, Garrett, Milane, Williams, and committee chair, Tolmachev.

“We’re thrilled to be gearing up for yet another promising conference — particularly in light of the praise we received after the 2014 event,” said MSL Society Board Chairman, Dr. Samuel Dyer. “We are excited to have Genzyme host our conference again at their Kendall Square headquarters—their support has been a big contributing factor to our organization’s critical early stage growth to support MSLs worldwide.”

Additional sponsors of the event include:

•     Leading KOL and Centers of Excellence profiler, Thought Leader Select

•     Medical communications agency, Springer Healthcare

•     Global biopharmaceutical company, Sanofi

To register or view more information on the conference, please visit http://conferences.themsls.org

About the MSL Society

The Medical Science Liaison Society (themsls.org (http://www.themsls.org)) is the only 501c3 non-profit organization dedicated to the global MSL profession. The society is exclusively dedicated to advancing the global MSL profession and helping MSLs become more effective in their careers through education and networking activities. The organization provides resources for professional growth and development opportunities by creating unique reports, hosting the only career center for MSLs and providing digital and live training programs.